dr. K. (Karina) Meijer

Head, Division of Haemostasis and Thrombosis

dr. K. (Karina) Meijer
E-mail:
k.meijer umcg.nl

Research

  1. 2019
  2. WiN Study Grp, Atiq, F., Fijnvandraat, K., van Galen, K. P. M., Laros-Van Gorkom, B. A. P., Meijer, K., ... Leebeek, F. W. G. (2019). BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. American Journal of Hematology, 94(8), E201-E205. https://doi.org/10.1002/ajh.25499
  3. Schutte, L. M., Cnossen, M. H., van Hest, R. M., Driessens, M. H. E., Fijnvandraat, K., Polinder, S., ... Kruip, M. J. H. A. (2019). Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study. BMJ Open, 9(4), [022719]. https://doi.org/10.1136/bmjopen-2018-022719
  4. van der Wall, S. J., van Rein, N., van den Bemt, B., Kruip, M. J. H. A., Meijer, K., te Boome, L. C. J., ... Huisman, M. (2019). Performance of idarucizumab as antidote of dabigatran in daily clinical practice. Europace, 21(3), 414-420. https://doi.org/10.1093/europace/euy220
  5. van Deukeren, D., Mauser-Bunschoten, E. P., Schutgens, R. E. G., Eikenboom, J., Meijer, K., Fijnvandraat, K., ... van Galen, K. P. M. (2019). The prevalence and burden of hand and wrist bleeds in von Willebrand disease. Haemophilia, 25(1), e35-e38. https://doi.org/10.1111/hae.13632
  6. 2018
  7. Amin, E. E., Bistervels, I. M., Meijer, K., Tick, L. W., Middeldorp, S., Mostard, G., ... ten Cate-Hoek, A. J. (2018). Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood, 132(21), 2298-2304. https://doi.org/10.1182/blood-2018-03-836783
  8. van der Pol, S., Jacobs, M., Meijer, K., Piersma-Wichers, M. G., Tieleman, RG., Postma, M., & van Hulst, M. (2018). To Bridge or Not to Bridge: Modelling Periprocedural Anticoagulation Management. E417. Poster session presented at 17th Biennial European Meeting of the Society for Medical Decision Making, Leiden, Netherlands. https://doi.org/10.1177/0272989X18793413
  9. Amin, E. E., Joore, M. A., ten Cate, H., Meijer, K., Tick, L. W., Middeldorp, S., ... ten Cate-Hoek, A. J. (2018). Clinical and economic impact of compression in the acute phase of deep vein thrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 16(8), 1555-1563. https://doi.org/10.1111/jth.14163
  10. OPTI-CLOT WIN Study Grp, Hazendonk, H. C. A. M., Heijdra, J. M., de Jager, N. C. B., Veerman, H. C., Boender, J., ... Cnossen, M. H. (2018). Analysis of current perioperative management with Haemate((R)) P/Humate P-(R) in von Willebrand disease: Identifying the need for personalized treatment. Haemophilia, 24(3), 460-470. https://doi.org/10.1111/hae.13451
  11. Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, R., Schutgens, R., ... Leebeek, F. W. G. (2018). Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B. Blood, 131(9), 1022-1031. https://doi.org/10.1182/blood-2017-09-804419
  12. Groeneveld, D. J., Sanders, Y. V., Adelmeijer, J., Mauser-Bunschoten, E. P., van der Bom, J. G., Cnossen, M. H., ... Leebeek, F. W. G. (2018). Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study. Thrombosis and Haemostasis, 118(1), 152-160. https://doi.org/10.1160/TH17-06-0397
  13. 2017
  14. van Galen, K. P. M., de Kleijn, P., Foppen, W., Eikenboom, J., Meijer, K., Schutgens, R. E. G., ... WiN Study Grp (2017). Long-term impact of joint bleeds in von Willebrand disease: A nested case-control study. Haematologica, 102(9), 1486-1493. https://doi.org/10.3324/haematol.2017.168617
  15. van Galen, K. P. M., Timmer, M. A., de Kleijn, P., Fischer, K., Foppen, W., Schutgens, R. E. G., ... WiN Study Grp (2017). Joint assessment in von Willebrand disease: Validation of the Haemophilia Joint Health score and Haemophilia Activities List. Thrombosis and Haemostasis, 117(8), 1465-1470. https://doi.org/10.1160/TH16-12-0967
  16. Loomans, J. I., Eckhardt, C. L., Reitter-Pfoertner, S. E., Holmstrom, M., Van Gorkom, B. L., Leebeek, F. W. G., ... Fijnvandraat, K. (2017). Mortality caused by intracranial bleeding in non-severe hemophilia A patients. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15(6), 1115-1122. https://doi.org/10.1111/jth.13693
  17. Abdul, S., Boender, J., Malfliet, J. J. M. C., Eikenboom, J., van Draat, K. F., Mauser-Bunschoten, E. P., ... Grp, S. (2017). Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease. Haemophilia, 23(3), 437-443. https://doi.org/10.1111/hae.13206
Previous 1 2 3 4 Next

ID: 116299